What is LiceGuard?
LiceGuard operates at the intersection of pediatric health and consumer product innovation. The company specializes in the development and distribution of non-toxic head lice treatment and prevention solutions, most notably the RobiComb Lice Zapping Comb. Their comprehensive product ecosystem, which includes specialized shampoos, repellent sprays, and elimination kits, is engineered to address the growing challenge of resistant lice strains. By focusing on safety and efficacy, LiceGuard serves a critical niche for parents and educators, effectively displacing harsh chemical treatments with reliable, technology-driven alternatives that prioritize long-term health outcomes.
How much funding has LiceGuard raised?
LiceGuard has raised a total of $51K across 1 funding round:
Debt
$51K
Debt (2021): $51K with participation from PPP
Key Investors in LiceGuard
PPP
Public-Private Partnership
What's next for LiceGuard?
With the infusion of this latest financing, LiceGuard is well-positioned to accelerate its market penetration and operational scaling. The company is expected to leverage these resources to enhance its research and development pipeline, potentially introducing new diagnostic tools or expanding its reach into international markets where demand for non-toxic health solutions is rising. As the firm transitions through its current Series B/C stage, the focus will likely shift toward optimizing supply chain logistics and strengthening its direct-to-consumer distribution channels to maintain its competitive edge in the specialized health and wellness landscape.
See full LiceGuard company page
